First Trust Advisors LP Axonics, Inc. Transaction History

First Trust Advisors LP

$108 Billion
Q4 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$49.38 - $63.75 $1.79 Million - $2.32 Million	36,332 New	36,332 $2.26 Million
Q2 2023 Aug 14, 2023	SELL	$47.99 - $60.21 $2.16 Million - $2.71 Million	-44,959 Reduced 88.6%	5,784 $291,000
Q1 2023 May 15, 2023	SELL	$52.6 - $67.34 $9.26 Million - $11.9 Million	-176,116 Reduced 77.63%	50,743 $2.77 Million
Q4 2022 Feb 09, 2023	BUY	$59.56 - $76.6 $5.83 Million - $7.5 Million	97,887 Added 75.9%	226,859 $14.2 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $1.19 Million - $1.6 Million	20,472 Added 18.87%	128,972 $9.09 Million
Q2 2022 Aug 12, 2022	BUY	$39.5 - $64.42 $3.27 Million - $5.33 Million	82,738 Added 321.16%	108,500 $6.15 Million
Q1 2022 May 13, 2022	SELL	$43.74 - $62.76 $673,158 - $965,876	-15,390 Reduced 37.4%	25,762 $1.61 Million
Q4 2021 Feb 08, 2022	SELL	$50.01 - $73.35 $578,065 - $847,852	-11,559 Reduced 21.93%	41,152 $2.31 Million
Q3 2021 Nov 15, 2021	BUY	$59.21 - $78.66 $235,063 - $312,280	3,970 Added 8.15%	52,711 $3.43 Million
Q2 2021 Aug 16, 2021	SELL	$51.39 - $66.9 $165,013 - $214,815	-3,211 Reduced 6.18%	48,741 $3.09 Million
Q1 2021 May 14, 2021	SELL	$49.14 - $59.89 $182,260 - $222,132	-3,709 Reduced 6.66%	51,952 $3.11 Million
Q4 2020 Feb 02, 2021	BUY	$42.19 - $51.5 $145,133 - $177,160	3,440 Added 6.59%	55,661 $2.78 Million
Q3 2020 Nov 05, 2020	SELL	$35.33 - $51.04 $647,987 - $936,124	-18,341 Reduced 25.99%	52,221 $2.67 Million
Q2 2020 Jul 22, 2020	BUY	$22.91 - $39.83 $939,149 - $1.63 Million	40,993 Added 138.64%	70,562 $2.48 Million
Q1 2020 May 06, 2020	BUY	$16.44 - $37.73 $486,114 - $1.12 Million	29,569 New	29,569 $751,000

Others Institutions Holding AXNX

# of Institutions

Shares Held

5.03M

Call Options Held

Put Options Held

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account